Bristol-Myers Squibb (BMY) call put ratio 1 call to 1.1 put into Wellington says it does not support Bristol-Myers' acquisition of Celgene
Bristol-Myers Squibb (NYSE: BMY) call put ratio 1 call to 1.1 put into Wellington says it does not support Bristol-Myers' acquisition of Celgene (CELG).